tennessee - The convenient one!

The new ulrich contrast agent injector for MRI - accumulator free!

ulrich medical is an independent medium-sized company with worldwide sales of innovative products in the field of medical technology. For 25 years ulrich contrast agent injectors are reliable partners for radiological clinics and practices. They ensure optimal contrast agent injection for computer and magnetic resonance tomography.

In 2007 a new injector joined the product family of ulrich medical. The new convenient tennessee is accumulator free and ready for use at any time. tennessee is not only applicable for MRI but also for CT and includes the comfortable touch terminal. The injector avoids permanent time-consuming charging and handling of heavy accumulators, therefore the daily routine is not interrupted. Due to a smooth workflow the injector is absolutely dependable for both patient and user.

Just like the other ulrich injectors tennessee is based on the special roll pump system. Therefore a previous loading of syringes is not necessary. The injection is directly made from media containers. Due to ulrich’s sensor technology for air detection and check valves in the patient hose of the two part hose system a safe examination is guaranteed.

tennessee is throughout flexible, comfortable and safe and will ease up your daily workflow!

06.12.2007

News • AI-driven diagnostics

Philips and Cortechs.ai expand neuroimaging partnership

Philips and Cortechs.ai have extended their collaboration to integrate AI-enabled quantitative neuroimaging analytics directly into MR systems. The partnership aims to provide radiologists with…

News • Blood flow measurement

Stress cardiac MRI tests may help improve angina diagnosis and treatment

A patient reports with chest pain, but in the coronary angiogram, the main heart arteries look clear, so it cannot be angina – right? A new study reveals that this approach can easily lead to…

News • Manganese MOF nanoparticles

New material to make MRI contrast agents greener, safer, sharper

Metal-organic frameworks (MOFs) serve as the basis for a novel type of MRI contrast agent, which the developers hope can outperform current agents while being less toxic for the patient.